SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3

Overview of antiviral drug candidates targeting coronaviral 3C‐like main proteases

(2021) Chun‐Chi Chen et al.   FEBS Journal

Targeting novel structural and functional features of coronavirus protease nsp5 (3CLpro, Mpro) in the age of COVID-19

(2021) Molly K. Roe et al.   JOURNAL OF GENERAL VIROLOGY

Diagnosis of COVID-19, vitality of emerging technologies and preventive measures

(2021) Muhammad Asif et al.   CHEMICAL ENGINEERING JOURNAL

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

(2020) Victor M Corman et al.   Eurosurveillance

BICP0 Negatively Regulates TRAF6-Mediated NF-κB and Interferon Activation by Promoting K48-Linked Polyubiquitination of TRAF6

(2020) Chong Cao et al.   Frontiers in Microbiology

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

(2020) Jasper Fuk-Woo Chan et al.   Emerging Microbes & Infections

Author Correction: A new coronavirus associated with human respiratory disease in China

(2020) Fan Wu et al.   NATURE

Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?

(2020) Jean-Michel Sallenave et al.   Frontiers in Immunology

Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants

(2020) Muhammad Tahir ul Qamar et al.   Journal of Pharmaceutical Analysis

Coronavirus Disease 2019–COVID-19

(2020) Kuldeep Dhama et al.   CLINICAL MICROBIOLOGY REVIEWS

Activation and evasion of type I interferon responses by SARS-CoV-2

(2020) Xiaobo Lei et al.   Nature Communications

Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach

(2020) Ahmad Abu Turab Naqvi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors

(2020) Alina S. Shomuradova et al.   IMMUNITY

Forkhead box O1-mediated ubiquitination suppresses RIG-I-mediated antiviral immune responses

(2020) Zhenling Ma et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Dual targeting of RIG-I and MAVS by MARCH5 mitochondria ubiquitin ligase in innate immunity

(2019) Yeon-Ji Park et al.   CELLULAR SIGNALLING

Cyclophilin A-regulated ubiquitination is critical for RIG-I-mediated antiviral immune responses

(2017) Wei Liu et al.   eLife

Methylcrotonoyl-CoA carboxylase 1 potentiates RLR-induced NF-κB signaling by targeting MAVS complex

(2016) Zhongying Cao et al.   Scientific Reports

Codon optimization enhances the expression of porcine β-defensin-2 in Escherichia coli

(2015) C.Y. Gao et al.   GENETICS AND MOLECULAR RESEARCH

MAVS Coordination of Antiviral Innate Immunity

(2015) Christine Vazquez et al.   JOURNAL OF VIROLOGY

Dynamic control of type I IFN signalling by an integrated network of negative regulators

(2015) Rebecca A. Porritt et al.   TRENDS IN IMMUNOLOGY